Advertisement
Home Tags Genetics

Tag: Genetics

Circulating exosomes have a distinct RNA profile in relapsing-remitting multiple sclerosis

Circulating Exosomes Have Distinct RNA Profile in MS

Serum exosomal expression of four microRNAs significantly decreased during relapse
The Runt-related transcription factor 1 gene may play a role in human proliferative diabetic retinopathy

RUNX1 May Play Role in Proliferative Diabetic Retinopathy

RUNX1 upregulated in CD31+ vascular endothelial cells from human PDR fibrovascular membranes
Close to half of breast cancer patients who choose to have a double mastectomy after genetic testing may not have the gene mutations known to raise the risk of additional cancers

Misunderstanding of BRCA Test Results Affects Mastectomy Rates

Half of average-risk patients with variants of uncertain significance may undergo bilateral mastectomy
Many survivors of childhood cancer have mutations in cancer-associated genes

AACR: Genetic Mutations Seen in Many Childhood Cancer Survivors

One in four children who lived through cancer developed another cancer by age 45, researchers say
Angiopoietin-like 3 deficiency is associated with reduced risk of coronary artery disease

ANGPTL3 Deficiency Linked to Reduced CAD Risk

Heterozygous carriers of ANGPTL3 loss-of-function mutations have reductions in TGs, LDL-C
BRCA testing has shifted from being primarily used in cancer patients to being used in unaffected women

BRCA Mutation Testing Shifts to Unaffected Women

From 2004 to 2014, greater percent of testing in unaffected women versus cancer patients
Genetic predisposition to hyperglycemia raises the odds of coronary artery disease (CAD)

Genetic Hyperglycemia Raises Risk of Coronary Artery Disease

Increased risk of coronary artery disease is separate from diabetes risk
Donepezil should not be prescribed to patients with mild cognitive impairment without first giving them a genetic test

Off-Label Donepezil Rx for MCI Could Be Risky for Some Patients

Medication has detrimental effect on patients with the K-variant of the butyrylcholinesterase gene
For patients with BRAF wild-type metastatic melanoma

Cost-Effectiveness Compared for Metastatic Melanoma Treatments

First-line pembrolizumab or nivolumab followed by second-line ipilumumab most cost-effective
In a brief report published in the March 2 issue of the New England Journal of Medicine

Gene Therapy Described in a Patient With Sickle Cell Disease

But treatment has only been given to one patient so far